Caribou Biosciences IncCRBU
Price$1.22

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $10M+0.4% YoYTTM through 30 Jun 2026
Net Income -$103.4MTTM through 30 Jun 2026
Free Cash Flow -$95.8MTTM through 30 Jun 2026

Margins

Current
Operating Margin-1,095.0%
Net Margin-1,030.4%

Returns

-24.6%ROE
-16.8%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio5.71x
Net Debt-$118.6Mnet cash position
Cash & Equivalents$26.2M

Quality Metrics

Altman Z-Score-6.03
Piotroski F-Score4 / 9
FCF Margin-954.7%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $11.2M
Diluted EPS-$1.08TTM
'21'22'23'24'25
FY2025: $-1.59

Dividend

No dividend

Capital Allocation

Capex Intensity-0.3%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.